Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine concentration comparison with ropivacaine for continuous adductor canal block after total knee arthroplasty
ChiCTR2000034775Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Nanchang University
- Start
- Jul 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine and ropivacaine in postoperative pain (5 arms), sponsored by The Second Affiliated Hospital of Nanchang University. Primary endpoint: Postoperative pain. Started Jul 2020; status: recruiting.
02
Drugs
dexmedetomidineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2000034775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034775.